© 2021 MJH Life Sciences and Opthalmology Times Europe. All rights reserved.
© 2021 MJH Life Sciences™ and Opthalmology Times Europe. All rights reserved.
November 12, 2021
Intra-arterial tPA treatment could provide benefits for patients with central retinal artery occlusion.
ImprimisRx President John Saharek shares an update on a few of the company's latest products during AAO 2021.
November 11, 2021
The American Academy of Ophthalmology's annual meeting will proceed November 12 to 15 in New Orleans, Louisiana.
A recently developed tool can help ophthalmologists to assess the quality of findings from real-world studies in retinal diseases. This will help them decide which results are most robust and applicable to their practice.
November 10, 2021
Dr Timothy G. Murray discusses the 5-year followup data from a large, consecutive case series of combined anterior and posterior segment surgery and the benefits of a single procedure for the recovery of vision and decreased risk.
November 09, 2021
Ophthalmologists’ close proximity to patients put them at higher risk of contracting the virus.
November 08, 2021
Evidence shows that higher corneal sensitivity may be associated with pain phenotypes, such as the presence of chronic pain involving the trigeminal system.
November 07, 2021
Allergan developed VUITY, which it noted is the first and only FDA-approved eye drop to treat presbyopia.
November 06, 2021
Dr Nathan Steinle discusses top-line results of the OAKS and DERBY trials, testing the efficacy of pegcetacoplan for the treatment of geographic atrophy.
November 05, 2021
A team of investigators from the University of Michigan may have unlocked a potential new recipe for counteracting the impact that COVID-19 has on patients with underlying disease processes such as type 2 diabetes.